Clinical Trial Update: Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update indicating completion of a study evaluating intranasal Dodecyl Creatine Ester (CBT101) in healthy male subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurological Diseases

Drugs mentioned

• CBT101 (Dodecyl Creatine Ester)

Snippet

Sponsor: Ceres Brain Therapeutics | Conditions: Neurologic Diseases, General | Phase 1 | Status: COMPLETED